Grant: Discovery Grants Program - Individual
University of Guelph
$37,000.00
Dynamic equilibria of membrane microdomains and protein modifications in central nervous system myelin
FY 2011-12
Summary
The myelin sheath is a membranous spiral that wraps around the axons (nerves) of the central nervous system (CNS), and enables them to transmit impulses efficiently. Diseases of myelin such as multiple sclerosis and Pelizaeus-Merzbacher affect CNS function and are extremely debilitating. The CNS myelin is formed by extensions of membranes of cells called oligodendrocytes - one oligodendrocyte can enwrap several different nerve fibers. The formation of myelin in early childhood is a complex process that occurs in stages. At each stage, gene expression must be strictly controlled to produce the right amounts of many different components that then need to be delivered to the correct location in the cell. Even in the mature CNS, there is constant turnover and replenishment of myelin proteins and lipids. When one looks at myelin in the electron microscope, one sees mainly compact myelin, but also less compact loop regions. An even closer look indicates that myelin consists of different ""microdomains"" that can be ""dissected"" out by biochemical extractions with detergents. These microdomains differ not so much in composition of their constituent proteins and lipids, but rather in how these proteins have been modified by different enzymes after synthesis (this last process is called ""post-translational modification""). Our research aims to understand how the modification pattern of CNS myelin proteins varies dynamically during development, and spatially in normal adult myelin. We look at the pattern of protein changes as an oligodendrocyte matures, primarily phosphorylation and deimination, because we consider that the balance of these changes is crucial to maintaining a healthy myelin sheath. As part of this endeavour, we look at the structures of one of the modifying enzymes (peptidylarginine deiminase) and of a major constituent protein (proteolipid protein) using a variety of complementary biochemical and biophysical techniques. The peptidylarginine deiminase enzyme represents a possible therapeutic target for multiple sclerosis, and potential inhibitors shall be evaluated functionally and structurally.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
121541-2009
Name nom
Harauz, George
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
37000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
3
Nb partie
5
Application title
Dynamic equilibria of membrane microdomains and protein modifications in central nervous system myelin
Keyword
NSERC
Application summary
The myelin sheath is a membranous spiral that wraps around the axons (nerves) of the central nervous system (CNS), and enables them to transmit impulses efficiently. Diseases of myelin such as multiple sclerosis and Pelizaeus-Merzbacher affect CNS function and are extremely debilitating. The CNS myelin is formed by extensions of membranes of cells called oligodendrocytes - one oligodendrocyte can enwrap several different nerve fibers. The formation of myelin in early childhood is a complex process that occurs in stages. At each stage, gene expression must be strictly controlled to produce the right amounts of many different components that then need to be delivered to the correct location in the cell. Even in the mature CNS, there is constant turnover and replenishment of myelin proteins and lipids. When one looks at myelin in the electron microscope, one sees mainly compact myelin, but also less compact loop regions. An even closer look indicates that myelin consists of different ""microdomains"" that can be ""dissected"" out by biochemical extractions with detergents. These microdomains differ not so much in composition of their constituent proteins and lipids, but rather in how these proteins have been modified by different enzymes after synthesis (this last process is called ""post-translational modification""). Our research aims to understand how the modification pattern of CNS myelin proteins varies dynamically during development, and spatially in normal adult myelin. We look at the pattern of protein changes as an oligodendrocyte matures, primarily phosphorylation and deimination, because we consider that the balance of these changes is crucial to maintaining a healthy myelin sheath. As part of this endeavour, we look at the structures of one of the modifying enzymes (peptidylarginine deiminase) and of a major constituent protein (proteolipid protein) using a variety of complementary biochemical and biophysical techniques. The peptidylarginine deiminase enzyme represents a possible therapeutic target for multiple sclerosis, and potential inhibitors shall be evaluated functionally and structurally.